acetylcysteine has been researched along with Peripheral Nerve Diseases in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.14) | 18.2507 |
| 2000's | 4 (28.57) | 29.6817 |
| 2010's | 6 (42.86) | 24.3611 |
| 2020's | 3 (21.43) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, Y; Ge, W; Liu, Y; Wang, J; Xu, H; Xu, Y; Yang, H; Zhou, L | 1 |
| El-Kharashi, OA; Elayat, WM; Habib, EK; Khairy, E; Khedr, SA; Mohamed, DI | 1 |
| Aboelhassan, R; El Wakeel, LM; Khalefa, HG; Shawki, MA | 1 |
| Domoto, R; Kawabata, A; Nakashima, K; Nishibori, M; Sekiguchi, F; Tsubota, M; Wake, H; Yamanishi, H; Yamasoba, D | 1 |
| Airey, C; Colosimo, M; Linnane, AW; Masci, PP; Schloss, JM; Vitetta, L | 1 |
| Barton, D; Grothey, A; Kottschade, L; Loprinzi, C; Wolf, S | 1 |
| Hamilton, AE; Reid, AJ; Shawcross, SG; Terenghi, G; Wiberg, M | 1 |
| Alden, CL; Cardoza, K; Csizmadia, E; Csizmadia, V; Fedyk, ER; Gallacher, M; Kadambi, VJ; O'Brien, L; Raczynski, A; Silverman, L; Simpson, C | 1 |
| Baker, SK; Lipson, DM | 1 |
| Abe, M; Amou, H; Fujii, S; Harada, T; Hiasa, M; Kagawa, K; Matsumoto, T; Miki, H; Nakamura, S; Nakano, A; Oda, A; Ozaki, S; Takeuchi, K; Watanabe, T | 1 |
| Asress, SA; Fischer, LR; Glass, JD; Jones, DP; Li, Y | 1 |
| Dudhgaonkar, SP; Jadhav, SH; Kataria, M; Kumar, D; Naik, AK; Prakash, VR; Tandan, SK | 1 |
| Bergmark, E; Calleman, CJ; Crofton, KM; Deng, H; Fennell, T; He, F; Tian, G; Wang, Y; Wu, Y; Zhang, S | 1 |
3 review(s) available for acetylcysteine and Peripheral Nerve Diseases
| Article | Year |
|---|---|
The Therapeutic Potential of Antioxidants in Chemotherapy-Induced Peripheral Neuropathy: Evidence from Preclinical and Clinical Studies.
Topics: Acetylcysteine; Antineoplastic Agents; Antioxidants; Humans; Oxidative Stress; Peripheral Nervous System Diseases | 2023 |
Nutraceuticals and chemotherapy induced peripheral neuropathy (CIPN): a systematic review.
Topics: Acetylcarnitine; Acetylcysteine; Antineoplastic Agents; Dietary Supplements; Fatty Acids, Omega-3; Glutamine; Glutathione; Humans; Peripheral Nervous System Diseases; Randomized Controlled Trials as Topic; Thioctic Acid; Trace Elements; Vitamins | 2013 |
Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies.
Topics: Acetylcarnitine; Acetylcysteine; Anticonvulsants; Antidepressive Agents, Tricyclic; Antineoplastic Agents; Baclofen; Calcium; Glutamine; Humans; Infusions, Intravenous; Ketamine; Magnesium; Naphthalenes; Nootropic Agents; Paclitaxel; Peripheral Nervous System Diseases; Pyridines; Randomized Controlled Trials as Topic; Vitamin E | 2008 |
2 trial(s) available for acetylcysteine and Peripheral Nerve Diseases
| Article | Year |
|---|---|
Evaluation of the effect of N-acetylcysteine on the prevention and amelioration of paclitaxel-induced peripheral neuropathy in breast cancer patients: a randomized controlled study.
Topics: Acetylcysteine; Adult; Aged; Antineoplastic Agents, Phytogenic; Biomarkers; Breast Neoplasms; Chemotherapy, Adjuvant; Drug Administration Schedule; Female; Humans; Kaplan-Meier Estimate; Lipid Peroxidation; Malondialdehyde; Middle Aged; Nerve Growth Factor; Paclitaxel; Peripheral Nervous System Diseases; Prospective Studies; Quality of Life | 2020 |
Complications & side effects. Supplements and CD4+ counts: study finds surprising results.
Topics: Acetylcarnitine; Acetylcysteine; Antioxidants; CD4 Lymphocyte Count; Dose-Response Relationship, Drug; HIV Infections; Humans; Peripheral Nervous System Diseases; Placebos; Thioctic Acid; Viral Load; Vitamins | 2004 |
9 other study(ies) available for acetylcysteine and Peripheral Nerve Diseases
| Article | Year |
|---|---|
N-acetylcysteine (NAC) alleviates the peripheral neuropathy associated with liver cirrhosis via modulation of neural MEG3/PAR2/ NF-ҡB axis.
Topics: Acetylcysteine; Animals; Free Radical Scavengers; Liver Cirrhosis; Male; NF-kappa B; Peripheral Nervous System Diseases; Random Allocation; Rats; Rats, Wistar; Receptor, PAR-2; RNA, Long Noncoding; Signal Transduction | 2020 |
Paclitaxel-induced HMGB1 release from macrophages and its implication for peripheral neuropathy in mice: Evidence for a neuroimmune crosstalk.
Topics: Acetylcysteine; Animals; Antibodies; Cells, Cultured; Clodronic Acid; Coculture Techniques; Ganglia, Spinal; HMGB1 Protein; Hyperalgesia; Imidazoles; Macrophages; Male; Membrane Proteins; Mice; Minocycline; Neurons; p300-CBP Transcription Factors; Paclitaxel; Peripheral Nervous System Diseases; Phosphoproteins; Phosphorylation; Proline; Pyridines; Pyruvates; Reactive Oxygen Species; Receptor for Advanced Glycation End Products; Receptors, CXCR4; Recombinant Proteins; Sciatic Nerve; Thiocarbamates; Thrombomodulin; Up-Regulation | 2018 |
N-acetylcysteine alters apoptotic gene expression in axotomised primary sensory afferent subpopulations.
Topics: Acetylcysteine; Animals; Apoptosis; Axotomy; bcl-2-Associated X Protein; Caspase 3; Cell Survival; Cytoprotection; Disease Models, Animal; Down-Regulation; Free Radical Scavengers; Ganglia, Spinal; Gene Expression Regulation; Male; Muscle, Skeletal; Peripheral Nerve Injuries; Peripheral Nerves; Peripheral Nervous System Diseases; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Wistar; RNA, Messenger; Sensory Receptor Cells; Skin; Up-Regulation | 2009 |
Effect of proteasome inhibitors with different chemical structures on the ubiquitin-proteasome system in vitro.
Topics: Acetylcysteine; Animals; Blotting, Western; Boronic Acids; Bortezomib; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Immunohistochemistry; Inhibitory Concentration 50; Mice; Mice, Inbred BALB C; Oligopeptides; PC12 Cells; Peripheral Nervous System Diseases; Protease Inhibitors; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Pyrazines; Rats; Ubiquitin | 2010 |
Vincristine-induced peripheral neuropathy in a neonate with congenital acute lymphoblastic leukemia.
Topics: Acetylcysteine; Antineoplastic Agents, Phytogenic; Carnitine; Drug Therapy, Combination; Free Radical Scavengers; Humans; Infant; Male; Peripheral Nervous System Diseases; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyridoxine; Vincristine; Vitamin B Complex | 2010 |
Delayed treatment with vitamin C and N-acetyl-L-cysteine protects Schwann cells without compromising the anti-myeloma activity of bortezomib.
Topics: Acetylcysteine; Animals; Antineoplastic Agents; Antioxidants; Ascorbic Acid; Autophagy; Boronic Acids; Bortezomib; Cell Line; Endoplasmic Reticulum; Free Radical Scavengers; Multiple Myeloma; Neuroprotective Agents; Peripheral Nervous System Diseases; Pyrazines; Rats; Schwann Cells | 2011 |
Absence of SOD1 leads to oxidative stress in peripheral nerve and causes a progressive distal motor axonopathy.
Topics: Acetylcysteine; Age Factors; Analysis of Variance; Animals; Axons; Bacterial Proteins; Calcium-Binding Proteins; Chromatography, High Pressure Liquid; DNA-Binding Proteins; Free Radical Scavengers; Glial Fibrillary Acidic Protein; Glutathione; Glutathione Disulfide; Luminescent Proteins; Mice; Mice, Knockout; Microfilament Proteins; Muscle Denervation; Muscle, Skeletal; Nerve Fibers; Neuromuscular Junction; Oxidation-Reduction; Oxidative Stress; Peripheral Nerves; Peripheral Nervous System Diseases; Presynaptic Terminals; Skin; Superoxide Dismutase; Superoxide Dismutase-1; Ubiquitin Thiolesterase; Ubiquitins | 2012 |
Role of oxidative stress in pathophysiology of peripheral neuropathy and modulation by N-acetyl-L-cysteine in rats.
Topics: Acetylcysteine; Animals; Behavior, Animal; Biomarkers; Disease Models, Animal; Free Radical Scavengers; Glutathione; Ligation; Male; Malondialdehyde; Neuralgia; Oxidative Stress; Pain Measurement; Peripheral Nervous System Diseases; Rats; Rats, Wistar; Reactive Oxygen Species; Sciatic Neuropathy; Superoxide Dismutase; Treatment Outcome | 2006 |
Relationships between biomarkers of exposure and neurological effects in a group of workers exposed to acrylamide.
Topics: Acetylcysteine; Acrylamide; Acrylamides; Adolescent; Adult; Biomarkers; Female; Hemoglobins; Humans; Male; Models, Theoretical; Occupational Diseases; Occupational Exposure; Peripheral Nervous System Diseases; Surveys and Questionnaires | 1994 |